We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...

Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials ...

Ebola spreads through bodily fluids and has a higher fatality rate, while COVID-19 spreads through the air and infects far ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nirmatrelvir/ritonavir and molnupiravir may be used for ...

CHICAGO (WLS) -- As the COVID-19 pandemic spreads, hospitals around the world have begun testing convalescent plasma as a potential treatment. The University of Chicago Medicine is one facility who is ...

The Food and Drug Administration (FDA) reiterated a warning against the use of ivermectin as a COVID-19 treatment amid growing reports of individuals taking the drug often used to treat parasitic ...

There’s no evidence showing that remdesivir, the first treatment approved for COVID-19, killed patients taking the drug. The antiviral drug is still approved by the U.S. Food and Drug Administration ...

Ebola and COVID-19 are viral diseases with different transmission methods and symptoms. Recent Ebola outbreaks in Africa have ...